ahlam1399
07-19-2016, 07:35 AM
BRIEF-Teva Pharmaceutical an**unces pricing of $15 bln of senior **tes
* An**unces pricing of $15 billion of senior **tes inconnection with pending acquisition of Actavis Genericshttp://feeds.feedburner.com/~ff/reuters/bondsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/bondsNews?a=upCWhKYJG74:wHRQhTclF3c:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/bondsNews?i=upCWhKYJG74:wHRQhTclF3c:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/bondsNews?a=upCWhKYJG74:wHRQhTclF3c:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/bondsNews?i=upCWhKYJG74:wHRQhTclF3c:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/bondsNews?a=upCWhKYJG74:wHRQhTclF3c:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/bondsNews/~4/upCWhKYJG74
* An**unces pricing of $15 billion of senior **tes inconnection with pending acquisition of Actavis Genericshttp://feeds.feedburner.com/~ff/reuters/bondsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/bondsNews?a=upCWhKYJG74:wHRQhTclF3c:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/bondsNews?i=upCWhKYJG74:wHRQhTclF3c:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/bondsNews?a=upCWhKYJG74:wHRQhTclF3c:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/bondsNews?i=upCWhKYJG74:wHRQhTclF3c:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/bondsNews?a=upCWhKYJG74:wHRQhTclF3c:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/bondsNews/~4/upCWhKYJG74